News | January 18, 2024
Taro announces merger agreement with Sun Pharma
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Subscribe To Our Newsletter & Stay Updated
